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Study Objectives: To compare the Nexfin cardiac output (CO) with the CO obtained from transthoracic
Doppler echocardiography (TTE) during routine cardiac function screening.
Design: Observational clinical study.
Setting: Echocardiography laboratory.
Patients: 40 ASA physical status 1 and 2 patients scheduled for routine TTE examination.
Interventions: None.
Measurements and Main Results: In 40 patients scheduled for routine TTE examination, we obtained
simultaneous CO measurements with Doppler ultrasound and derived from Nexfin blood pressure
measurements. Correlation and level of agreement between Nexfin and TTE were analyzed using
Pearson correlation coefficient and Bland-Altman plots. The Pearson correlation coefficient for Nexfin
versus TTE was 0.68 (CI: 0.46 - 0.82, P b 0.0001). Bland-Altman analysis showed a bias of 0.51 ± 1.1
L/min and limits of agreement of -1.6 to 2.6 L/min, with a percentage error of 39%.☆ This work was performed at the Department of Cardiology of the Spaarne Hospital, Hoofddorp, The Netherlands.
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305Arterial waveform analysis for CO monitoringConclusions: Considering limits of precision of CO measurements with Doppler echocardiography
(± 30%), the agreement between noninvasive CO measurement with the Nexfin and TTE is reasonable.
© 2012 Elsevier Inc.Open access under the Elsevier OA license.1. Introduction
Maintenance of adequate tissue perfusion and oxygena-
tion remains the primary therapeutic goal in the perioperative
and intensive care settings. Monitoring of cardiac output
(CO) is useful to meet this therapeutic goal. Thermodilution
estimates are traditionally considered the gold standard for
clinical CO measurements. However, these techniques
require intravascular placement of thermodilution catheters,
such as the pulmonary artery catheter [1,2]. Therefore,
noninvasive methods for CO monitoring have become
increasingly important in order to avoid the risk of invasive
techniques [3].
Recently, the Nexﬁn monitor has become available,
which uses updated implementation of the Finapres
method for noninvasive, beat-to-beat blood pressure (BP)
developed by Wesseling et al [4]. This method is based on
the volume-clamp method introduced by Peńãz [5] and the
physiological calibration (“physiocal”) criteria of Wessel-
ing and provides continuous reconstructed brachial arterial
BP waveforms [6]. Bogert et al described a pulse contour
method to compute CO from the Nexﬁn-derived contin-
uous noninvasive arterial BP waveforms [7]. The method
uses the pulsatile systolic area in combination with age-
related aortic vascular characteristics for calculation of CO.
This algorithm shows good agreement with thermodilution-
based estimates of CO [7].
The second most frequently used method for CO
measurements is Doppler echocardiography. The level of
agreement between Doppler echocardiography [8] and
Nexﬁn CO has not been investigated. We therefore
compared CO measurements derived from Nexﬁn noninva-
sive continuous arterial waveforms with Doppler echocardi-
ography CO as a reference method. We hypothesized that
noninvasive arterial waveform analysis may provide a
practical tool for CO measurement.2. Materials and methods
2.1. Subjects
The Institutional Review Board of the VU University
Medical Center approved the study and waived the
requirement for written, informed consent. In this obser-
vational study patients (n = 40) aged 18 years or older,
who were scheduled for routine transthoracic echocardi-
ography (TTE) examination as part of their outpatient
evaluation, were included. Patients with peripheral vasculardisease or signiﬁcant cardiac arrhythmias were excluded
from the study.
2.2. Study protocol and measurements
Cardiac output measurements were performed with
patients placed in the left lateral position in a quiet,
temperature-controlled room. An appropriate size ﬁnger
cuff was applied to the midphalanx of the middle ﬁnger of
the right hand according to the manufacturer's instructions.
The Nexﬁn (BMEYE, Amsterdam, the Netherlands) uses
ﬁnger cuff technology, which was developed in the 1980s
based on the volume clamp methodology by Peńãz [5].
Brieﬂy, volume-clamping keeps the ﬁnger artery at its
unloaded volume; at the point at which ﬁnger cuff pressure
and intra-arterial pressure are equal, transmural pressure is
zero. The arteries are kept at this unloaded diameter by
changing ﬁnger cuff pressure in parallel with intra-arterial
pressure. Cuff pressure thus provides an indirect measure of
intra-arterial pressure. Possible gravitational hydrostatic
effects are compensated by the heart reference system and
brachial artery pressure is reconstructed from the ﬁnger
pressure with physiological models that were described
earlier [9]. Cardiac output is derived from the reconstructed
brachial arterial waveforms and a model of the arterial input
impedance, based on patient age, gender, height, and weight.
Simultaneously, CO was measured by transthoracic echo-
Doppler by a trained echocardiologist (AF, AJV) with a
Vivid 7 equipped with a 2.5 MHz transthoracic probe (GE
Health Care, Hoevelaken, the Netherlands). Cardiac output
was obtained from the area of the left ventricular outﬂow
tract (LVOTarea), the time velocity integral (TVI) in the left
ventricular outﬂow tract (TVILVOT), and heart rate [HR; CO
= stroke volume (SV) × HR; SV = LVOTarea × TVILVOT).
LVOTarea was calculated from the LVOT diameter (D)
derived from a parasternal long-axis view with the formula:
LVOTarea = π(d/2)2. The TVILVOT was obtained in the 3 or
5-chamber apical view with pulsed wave Doppler 0.5 cm
proximal to the aortic valve. Heart rate was derived from
simultaneous electrocardiogram recordings. Five time-
matched measurements were obtained that were averaged
for CO comparison with the Nexﬁn.
2.3. Statistical analysis
Statistical analyses were carried out using GraphPad Prism
version 5.01 (GraphPad software Inc., La Jolla, CA, USA) and
SPSS statistical software version 15.0 (SPSS, Inc., Chicago,
IL, USA). The association between COTTE and CONexﬁn was
306 A.G.E. van der Spoel et al.analyzed using Pearson's correlation coefﬁcient. Level of
agreement was analyzed by constructing Bland–Altman plots.
P-values b 0.05 were considered statistically signiﬁcant.ig. 1 Mean cardiac output (CO) determined by Nexﬁn did not
iffer from CO measured by transthoracic Doppler echocardiogra-
hy (TTE). Error bars = standard deviation. NS = not signiﬁcant.3. Results
A total of 18 men and 22 women were included in the
study. Mean age was 57 (SD: 15) years, mean body weight
was 82 (SD: 16) kg, and mean body mass index was 27 (SD:
4) kg/m2 (Table 1). For all patients, sufﬁcient quality of
echocardiographic examinations and Nexﬁn arterial wave
forms were derived.
3.1. Comparison of COTTE and CONexfin
Cardiac output measured by TTE ranged from 3.6 to 8.0
L/min and CO obtained by the Nexﬁn ranged from 2.9 to 8.6
L/min. There was no difference in mean COTTE and CONexﬁn
[COTTE: 5.9 (SD: 1.2) vs CONexﬁn 5.3 (SD: 1.4), P = 0.08]
(Fig. 1) and patient characteristics, such as body weight and
BP treatment, did not interact with CO measurements.
CONexﬁn showed an acceptable correlation with COTTE (r =
0.68 (95% CI 0.46 - 0.82, P b 0.0001) (Fig. 2). Level of
agreement as assessed with Bland-Altman analysis showed a
mean bias between COTTE and CONexﬁn of 0.51 L/min
(precision of 1.1 L/min). Limits of agreement betweenTable 1 Patient characteristics, history, and medication
Patient characteristics Mean ± SD Range
Age (yrs) 57 ± 15 27 – 81
Height (cm) 175 ± 10 155 – 195
Weight (kg) 82 ± 16 53 – 120
BMI (kg/m2) 27 ± 4 19 – 37
Heart rate (bpm) 70 ± 12 53 – 104
SBP (mmHg) 144 ± 17 111 – 194
DPB (mmHg) 84 ± 10 68 – 123
Gender (M/F) (%) 18/22 55/45
History n/n %
diabetes (yes/no) 2/38 5/95
hypertension (yes/no) 10/30 25/75
myocardial infarction (yes/no) 6/34 15/85
Medication n/n %
β-blocker (yes/no) 13/27 33/67
diuretics (yes/no) 7/33 18/82
calcium blocker (yes/no) 6/34 15/85
ACE inhibitor (yes/no) 6/34 15/85
AR blocker (yes/no) 8/32 20/80
nitrates (yes/no) 6/34 15/85
BMI = body mass index, SBP = systolic blood pressure, DBP = diastolic
blood pressure, ACE = angiotensin-converting enzyme, AR = androgen
receptor.F
d
pCOTTE and CONexﬁn ranged from -1.6 to 2.6 L/min (Fig. 3).
The percentage error, calculated as 2 × SD/μ, was 39%.4. Discussion
The present study showed that the agreement between CO
derived from pulse contour analysis based on noninvasive
continuous BP waveforms by Nexﬁn and transthoracic
Doppler echocardiography was acceptable. Transthoracic
Doppler echocardiography is an accepted reference method
for noninvasive CO measurements [8]. Our data showed a
percentage error of 39% for Nexﬁn CO measurements,Fig. 2 Relationship between cardiac output (CO) determined by
transthoracic Doppler echocardiography (COTTE) and CO simulta-
neously obtained by Nexﬁn HD (CONexﬁn) in 40 patients scheduled
for routine echocardiography. Solid line = identity line. The
relationship between COTTE and CONexﬁn is represented in a
correlation coefﬁcient (R-value) with a 95% conﬁdence interval
(95% CI). A P-value b 0.05 was considered statistically signiﬁcant.
Fig. 3 Bland-Altman plots between cardiac output (CO)
determined by transthoracic Doppler echocardiography (COTTE)
and CO simultaneously obtained by Nexﬁn (CONexﬁn) in 40
patients scheduled for routine echocardiography. Bold line = mean
difference (Bias), dashed lines = 95% limits of agreement (LOA).
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transthoracic Doppler echocardiography [10]. This ﬁnding
suggests that continuous CO derived from the Nexﬁn may
provide a valuable alternative to current (noninvasive) CO
measurement techniques.
Critically ill patients often require extensive hemody-
namic monitoring that includes CO. As invasive techniques
bear the risk of signiﬁcant complications that contribute to
increased morbidity and even mortality [1], less invasive
techniques have been developed. Pulse contour analysis for
CO monitoring is an interesting technique as it derives CO
estimates from beat-to-beat computation of SV from BP
waveforms. As a result, continuous CO measurements are
generated, whereas dilution methods provide only intermit-
tent CO measurements.
Several pulse contour systems are available and consist of
a pulse analysis algorithm that usually requires vascular
access for arterial pulse wave detection and system
calibration via an indicator dilution method. Interestingly,
Nexﬁn measures continuous BP noninvasively, and its pulse
contour algorithm does not require calibration [7]. In patients
with a contraindication to vascular access (eg, after
thrombolysis) or without easy vascular access due to
anatomical variations or scarring due to multiple previous
arterial punctures, Nexﬁn CO may be considered a useful
alternative. In addition, it may be used temporarily for CO
monitoring until vascular access is obtained. However, its
clinical value in more extreme hemodynamic circumstances,
such as during surgery in critically ill patients or in
conditions of peripheral vasoconstriction or hypothermia,
remains to be established in large-scale validation studies.
As previously mentioned, the Nexﬁn monitor uses the
volume-clamp method of Peńãz in combination with the
physiocal criteria of Wesseling et al for the measurement of
pressure [4,5]. This earlier developed Modelﬂow method
[11] calculates ﬂow from BP pulsation using a three-elementWindkessel model of aortic input impedence, and has been
validated in various settings [12-22]. Wesseling et al showed
that the model estimated CO with a mean difference of 7%,
with an SD of 22%, which was further improved to 2%, with
an SD of 8% after single calibration with thermodilution CO
[11]. The Modelﬂow algorithm performed well during
cardiac surgery [15], septic shock [16], and hypovolemia
[18,23]. The Nexﬁn CO-trek algorithm that was developed
more recently also uses a three-element Windkessel model.
However, instead of calculating SV by integrating the
computed ﬂow curve, it calculates SV immediately by
dividing the pulsatile systolic area by input impedance. Input
impedance is determined at each beat and nonlinearly
depending on mean arterial pressure. This should ensure
reliable computation of SV for changing hemodynamic
states. CO-trek was developed to work with noninvasive BP,
showing improvements in accuracy and precision compared
with the Modelﬂow [7].
Our present data indeed showed reasonable agreement
with TTE Doppler and conﬁrmed the recent studies of Bogert
et al [7] and Van Geldorp et al [24]. In contrast, Stover et al
recently concluded that invasive hemodynamic monitoring in
the intensive care unit could not be replaced by noninvasive
hemodynamic monitoring with the Nexﬁn [25]. However, the
mean bias between thermodilution CO and Nexﬁn in their
studywas 0.23 L/min, with limits of agreement of ± 2.1 L/min
and a percentage error of 29%. Considering the criteria
formulated by Critchley and Critchley [10], these results
should be regarded as promising. Interestingly, in their meta-
analysis, Peyton et al showed that the 30% criteria were not
realistic in clinical studies [26]. With mean percentage errors
of 41%, 42%, 45%, and 43% for, respectively, pulse contour,
esophageal Doppler, partial carbon dioxide rebreathing, and
transthoracic electrical bioimpedance, none of these methods
met the Critchley and Critchley criteria for acceptability of
agreement. According to Peyton et al, the relevance of the
criteria should be reassessed. They proposed a percentage
error of ± 45% [26].
Although they were reasonable, the bias and percentage
error in our results were larger than what was observed in
previous studies [7,24]. In addition, previous studies that
compared Modelﬂow with Doppler CO showed more
accurate agreement [17,20]. In contrast to these two studies,
we included patients who were scheduled for routine TTE
instead of healthy subjects. This action may have contributed
to variation in our measurements, but the heterogeneity of the
study population may better reﬂect clinical practice.
Furthermore, we determined CO in the LVOT, as opposed
to the supine position, which allows CO measurement in the
ascending aorta by placing the Doppler probe in the
suprasternal notch. Other differences were in the proportion
of CO ﬂowing through the site of measurement (full
proportion of the LVOT vs 95% of CO in the ascending
aorta) and body positioning (left lateral vs supine). Body
position may have skewed the accuracy of the heart reference
system of the Nexﬁn monitor.
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LVOT measurements offer the advantage of the laminar
blood for representative TVI measurements. Second, the
circular nature of the LVOT with little diameter changes
during the cardiac cycle allows for reliable CSA estimation
[27]. Importantly, McLean and co-workers showed in
critically ill patients that the LVOT Doppler method
compared with other TTE methods had the best agreement
with thermodilution [28].
Several limitations of our study have to be considered in
the interpretation of our results. Although we marked the
timing of the Doppler CO measurements in the Nexﬁn
recording, it proved difﬁcult to absolutely synchronize CO
measurements. This was circumvented by averaging Nexﬁn
measurements before and after the mark. This methodmade it
necessary to exclude patients with cardiac arrhythmias. In
addition, both COmeasurements were repeated 5 times in one
patient and the results were subsequently averaged. Second,
agreement measurements were not performed after induction
of variations in CO (such as exercise in the head-up position).
Finally, patients with arrhythmias and peripheral vascular
disease were excluded from this study, a situation that limits
extrapolation to the clinical patient population.4.1. Conclusions
In conclusion, our data suggest that Nexﬁn CO
measurements show reasonable agreement with CO mea-
sured by transthoracic Doppler echocardiography. This
extends current methods for noninvasive CO monitoring,
and its simple use, short time to ﬁrst measurement, and low
risk of complications are attractive. However, validation to
hemodynamic variation and other patient groups needs to be
further explored in future studies.References
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